Appendix B.
Indonesia (n = 160) |
Malaysia (n = 18) |
Philippines (n = 51) |
Singapore (n = 15) |
Thailand (n = 54) |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | n | % | ||
Year level | |||||||||||
1 | 37 | 23 | 3 | 17 | 0 | 0 | 2 | 13 | 5 | 9 | |
2 | 41 | 26 | 1 | 6 | 16 | 31 | 1 | 7 | 12 | 22 | |
3 | 31 | 19 | 5 | 28 | 7 | 14 | 2 | 13 | 11 | 20 | |
4 | 23 | 14 | 9 | 50 | 9 | 18 | 5 | 33 | 10 | 19 | |
5 | 23 | 14 | 6 | 12 | 3 | 20 | 16 | 30 | |||
≥6 | 5 | 3 | 13 | 25 | 2 | 13 | |||||
Place of work | |||||||||||
Dedicated COVID hospital | 13 | 8 | 1 | 6 | 1 | 2 | 1 | 7 | 12 | 22 | |
Hybrid COVID hospital | 146 | 91 | 12 | 67 | 49 | 96 | 14 | 93 | 39 | 72 | |
Non-COVID | 1 | 1 | 5 | 28 | 1 | 2 | 0 | 0 | 3 | 6 | |
Cancelled activities | |||||||||||
Outpatient clinics | 25 | 16 | 10 | 56 | 39 | 76 | 5 | 33 | 18 | 33 | |
Conferences | 112 | 70 | 14 | 78 | 49 | 96 | 12 | 80 | 37 | 69 | |
Effect on research projects | |||||||||||
Proceed as usual | 37 | 23 | 5 | 28 | 14 | 27 | 2 | 13 | 29 | 54 | |
Increase in research | 14 | 9 | 2 | 11 | 12 | 24 | 4 | 27 | 10 | 19 | |
Decrease in research | 53 | 33 | 10 | 56 | 18 | 35 | 9 | 60 | 8 | 15 | |
No ongoing research | 55 | 34 | 1 | 6 | 7 | 14 | 0 | 0 | 7 | 13 | |
Missed opportunities | |||||||||||
Poster | 46 | 29 | 6 | 33 | 20 | 39 | 7 | 47 | 11 | 20 | |
Observership | 70 | 44 | 2 | 11 | 15 | 29 | 5 | 33 | 37 | 69 | |
Job interview | 6 | 4 | 0 | 0 | 2 | 4 | 1 | 7 | 0 | 0 | |
Research fellowship | 16 | 10 | 0 | 0 | 0 | 0 | 2 | 13 | 0 | 0 | |
Clinical fellowship | 32 | 20 | 6 | 33 | 4 | 8 | 1 | 7 | 1 | 2 | |
Any of the above | 119 | 74 | 12 | 67 | 29 | 57 | 10 | 67 | 43 | 80 | |
Device ownership | |||||||||||
Smartphone | 155 | 97 | 18 | 100 | 51 | 100 | 15 | 100 | 48 | 89 | |
Tablet | 56 | 35 | 8 | 44 | 38 | 75 | 9 | 60 | 42 | 78 | |
Laptop computer | 150 | 94 | 16 | 89 | 49 | 96 | 14 | 93 | 38 | 70 | |
Desktop computer | 12 | 8 | 1 | 6 | 9 | 18 | 4 | 27 | 15 | 28 | |
Internet access | |||||||||||
Mobile data | 150 | 94 | 15 | 83 | 48 | 94 | 14 | 93 | 47 | 87 | |
Postpaid subscription | 56 | 35 | 13 | 72 | 32 | 63 | 11 | 73 | 23 | 43 | |
Hospital Internet | 64 | 40 | 3 | 17 | 36 | 71 | 11 | 73 | 36 | 67 | |
Online learning platform available? | |||||||||||
Yes | 68 | 43 | 10 | 56 | 13 | 25 | 2 | 13 | 24 | 44 | |
No | 57 | 36 | 8 | 44 | 36 | 71 | 13 | 87 | 25 | 46 | |
Not sure | 34 | 21 | 0 | 0 | 1 | 2 | 0 | 0 | 5 | 9 | |
Who initiates learning activities? | |||||||||||
Trainees | 76 | 48 | 8 | 44 | 39 | 76 | 12 | 80 | 47 | 87 | |
Mentors | 135 | 84 | 13 | 72 | 41 | 80 | 10 | 67 | 33 | 61 | |
Administrators | 14 | 9 | 1 | 6 | 5 | 10 | 2 | 13 | 6 | 11 | |
Ongoing learning activities | |||||||||||
Telemedicine or virtual clinic | 111 | 69 | 6 | 33 | 30 | 59 | 7 | 47 | 41 | 76 | |
Virtual morbidity and mortality | 68 | 43 | 2 | 11 | 37 | 73 | 13 | 87 | 31 | 57 | |
Virtual grand rounds | 124 | 78 | 7 | 39 | 45 | 88 | 10 | 67 | 32 | 59 | |
Simulation laboratories | 10 | 6 | 0 | 0 | 6 | 12 | 0 | 0 | 3 | 6 | |
Research activities | 36 | 23 | 1 | 6 | 28 | 55 | 7 | 47 | 21 | 39 | |
Mentoring | 69 | 43 | 4 | 22 | 17 | 33 | 6 | 40 | 14 | 26 | |
How often do you watch webinars? | |||||||||||
Never | 0 | 0 | 3 | 17 | 1 | 2 | 0 | 0 | 13 | 24 | |
1× a month or less | 1 | 1 | 5 | 28 | 12 | 24 | 5 | 33 | 24 | 44 | |
1× a week | 13 | 8 | 4 | 22 | 21 | 41 | 6 | 40 | 7 | 13 | |
2× a week or more | 146 | 91 | 6 | 33 | 17 | 33 | 4 | 27 | 10 | 19 | |
Will COVID-19 have a negative impact on your training? | |||||||||||
Yes | 124 | 78 | 9 | 50 | 40 | 78 | 9 | 60 | 39 | 72 | |
No | 4 | 3 | 4 | 22 | 7 | 14 | 3 | 20 | 9 | 17 | |
Not sure | 32 | 20 | 5 | 28 | 4 | 8 | 3 | 20 | 6 | 11 | |
Have you worked in COVID-19 units? | |||||||||||
Yes | 42 | 26 | 3 | 17 | 30 | 59 | 3 | 20 | 29 | 54 | |
No | 117 | 73 | 15 | 83 | 21 | 41 | 11 | 73 | 23 | 43 | |
Not indicated | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 7 | 2 | 4 | |
Describe your hospital's PPE | |||||||||||
Appropriate and adequate | 81 | 51 | 12 | 67 | 30 | 59 | 15 | 100 | 41 | 76 | |
Inappropriate and/or inadequate | 68 | 43 | 6 | 33 | 21 | 41 | 0 | 0 | 11 | 20 | |
No PPE available | 9 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Not indicated | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | |
Is testing available for health workers? | |||||||||||
Routine | 45 | 28 | 2 | 11 | 8 | 16 | 1 | 7 | 5 | 9 | |
Only with exposure | 113 | 71 | 16 | 89 | 41 | 80 | 14 | 93 | 47 | 87 | |
No testing available | 0 | 0 | 0 | 0 | 2 | 4 | 0 | 0 | 0 | 0 | |
Not indicated | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 |
PPE, personal protective equipment.